Belantamab Mafodotin Combination Therapy

A Phase I/II Study of the Safety, Tolerability and Efficacy of Belantamab Mafodotin (GSK2857916) in Combination With Iberdomide (CC-220)/Dexamethasone Versus Belantamab Mafodotin (GSK2857916)/Dexamethasone in Relapsed Refractory Multiple Myeloma

Near Add Your Location

Sorting 35 by

  • Not currently accepting
  • Show Principal Investigator
  • Not currently accepting
  • Not currently accepting
  • Not currently accepting
  • Not currently accepting
  • Not currently accepting
  • Not currently accepting
  • Not currently accepting
  • Not currently accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.